Froome test ‘a disaster’ for cycling
EX-UCI chief says Sky’s credibility in doubt
● Former UCI president Pat Mcquaid has called Chris Froome’s adverse drugs test “a disaster” for cycling and claimed Team Sky could lose all credibility as a result.
Four-time Tour de France winner Froome had double the permitted level of the asthma drug salbutamol in a urine test taken during his victory in La Vuelta in September.
The result is not automatically classified as a positive test and the 32-year-old has not been suspended, but he must provide a satisfactory explanation for the adverse findings or he faces a ban and the loss of his Vuelta title.
Froome has denied any wrongdoingandsaidheisproviding all the necessary information to the UCI, but Irishman Mcquaid, who was president of the world governing body from 2005 to 2013, told BBC Sport Froome would find it “very hard to avoid a ban”.
“Idon’tseehowchrisfroome can turn around like he did and say ‘I played by the rules, I broke no rules’,” Mcquaid said.
“The fact is, he has broken a rule. The fact is his urine sample was twice the permitted limit. It’s up to him to go and prove that he could have done otherwise. We’re now three
2 months down the road, and they haven’t found a solution or a resolution to it yet.”
The situation is a complicated one. There are possible explanations as to why an athlete would return such a high reading of salbutamol even if they only took the allowed dosage, but the onus is on Froome to prove his innocence.
News of Froome’s adverse test increased the pressure on Team Sky. It comes soon after the inconclusive investigation into the contents of the mystery medical package delivered to Sir Bradley Wiggins at a race in 2011, and revelations over Wiggins’ use of therapeutic use exemptions before major races.
Mcquaid said Froome’s situation was a massive problem for Sir Dave Brailsford’s team. He added: “It’s going to be very difficult to see how they can come out of this with any credibility at all, to be honest with you. It begs a lot of questions.”